Project for vaccination of unvaccinated children in selected hard to reach areas of Sabah State
WHO
Project for vaccination of unvaccinated children in selected hard to reach areas of Sabah State
Request for proposal
Reference:
WPRO/2025-04/CO-MYS/265403
Beneficiary countries or territories:
Malaysia
Registration level:
Basic
Published on:
29-Apr-2025
Deadline on:
23-May-2025 17:00 (GMT 8.00)
Description
The primary purpose of this contract is to carry out the special vaccination project in the Sabah State focusing on ALCs and unvaccinated children for measles and rubella, under the guidance of the National Consultant (STC) working for WHO to support the special vaccination project.
Please use Tender Notice No. 265403 as subject to all submission. Only successful candidates will be contacted.
Please refer to attached RFP for details of the requirement.
Yahmini Nalaiah - wproungm@who.int
51201604
-
Diphteria vaccine
51201606
-
Hemophilus influenzae vaccine
51201607
-
Hepatitis B virus vaccine
51201608
-
Influenza virus vaccine
51201609
-
Measles virus vaccine
51201610
-
Meningococcal vaccine
51201615
-
Pneumococcal vaccine
51201616
-
Poliovirus vaccine
51201617
-
Rabies vaccine
51201618
-
Rota virus vaccine
51201621
-
Tetanus vaccine
51201623
-
Typhoid vaccine
51201624
-
Varicella virus vaccine
51201625
-
Yellow fever vaccine
51201626
-
Hepatitis A virus vaccine
51201627
-
Haemophilus B vaccine
51201628
-
Measles and mumps and rubella virus vaccine
51201629
-
Diphtheria and tetanus toxoids absorbed
51201631
-
Diptheria and tetanus toxoids and acellular pertussis vaccine
51201632
-
Diptheria and tetanus and wholecell pertussis vaccine
51201633
-
Haemophilus influenzae b with diptheria and tetanus and acellular pertussis
51201634
-
Haemophilus influenzae B with diptheria and tetanus and wholecell pertussis conjugated vaccine
51201646
-
Measles and rubella virus vaccine
51201648
-
Rubella and mumps virus vaccine
51201652
-
COVID19 - Pfizer Biontech
51201653
-
COVID19 - Moderna
51201654
-
COVID19 - Sputnik V
51201655
-
COVID19 - AstraZeneca
51201656
-
COVID19 - Johnson & Johnson
51201657
-
Malaria vaccine
51201658
-
Cholera vaccine
51201659
-
COVID 19 - Unspecified
51201660
-
Ebola vaccine
80101504
-
Strategic planning consultation services
80101505
-
Corporate objectives or policy development
80101509
-
Government affairs and community relations consultation service
80101511
-
Human resources consulting service
80101513
-
Process and procedures management consultation service
80101601
-
Feasibility studies or screening of project ideas
80101602
-
Regional or location studies for projects
80101603
-
Economic or financial evaluation of projects
80101604
-
Project administration or planning
80101606
-
Project monitoring and evaluation
80101607
-
Project impact assessment
80151604
-
Import procurement services